a public good project by the
Synthesis
Company
of California

© 2026

Shinichi Ikuta | doi.page

0 works0 citations0 h-index

Shinichi Ikuta

Japan Advanced Institute of Science and Technology(JP)Miwa Hospital(JP)

Publications by Year

Research Areas

Hepatocellular Carcinoma Treatment and Prognosis, Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Disease Diagnosis and Treatment, Gallbladder and Bile Duct Disorders

Most-Cited Works

→ Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer(2018)385 cited
→ Management bundles for candidaemia: the impact of compliance on clinical outcomes(2014)67 cited
→ Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery(2010)56 cited
→ A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)(2014)54 cited
Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional Setting.(2015)
→ Preoperative C‐reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma(2019)31 cited
→

Allogenic blood transfusion is an independent risk factor for infective complications after less invasive gastrointestinal surgery

(2003)

25 cited

Risk of abscess formation after liver tumor radiofrequency ablation: a review of 8 cases wtih a history of enterobiliary anastomosis.(2014)

Impact of Itraconazole After First-line Chemotherapy on Survival of Patients with Metastatic Biliary Tract Cancer.(2015)

→ Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas(2013)18 cited